Imovax Polio Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Use In Pregnancy & Lactation Side Effects Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per 0.5 mL Inactivated poliovirus type 1 (Mahoney strain) 29 D-antigen unit, inactivated poliovirus type 2 (MEF-1 strain) 7 D-antigen unit, inactivated poliovirus type 3 (Saukett strain) 26 D-antigen unit

Indications/Uses

As primary vaccination & booster for the prevention of poliomyelitis in infants, childn & adults.

Click to view Imovax Polio detailed prescribing information

Dosage/Direction for Use

IM/SC Primary vaccination From 2 mth of age 3 successive inj at intervals of 1 or 2 mth. From 6 wk of age Follow 6, 10, 14-wk schedule. Non-vaccinated adult 2 successive inj at intervals of 1 or, preferably, 2 mth. Booster Administer every 5 yr in childn & adolescent, & every 10 yr in adult. Adult A 3rd dose (1st booster) is administered 8-12 mth after the 2nd inj. Childn 2 yr A 4th dose (1st booster) is administered 1 yr after the 3rd inj.

Click to view Imovax Polio detailed prescribing information

Contraindications

Hypersensitivity to Imovax Polio, neomycin, streptomycin or polymyxin B. Allergic reaction after previous inj of Imovax Polio or vaccine containing the same substances. Postpone vaccination in case of fever or acute disease.

Click to view Imovax Polio detailed prescribing information

Special Precautions

Do not inj intravascularly. Risk of bleeding during IM administration in patients w/ blood disorders eg, thrombocytopenia or clotting disorders. Immune response to vaccine may be reduced in patients under immunosuppressive therapy (eg, corticosteroids, cytotoxic drugs, RT) or those w/ immunodeficiency/immunosuppression (eg, AIDS). Contains phenylalanine, which may be dangerous for patients w/ phenylketonuria.

Click to view Imovax Polio detailed prescribing information

Use In Pregnancy & Lactation

Click to view Imovax Polio detailed prescribing information

Adverse Reactions

Inj site pain; fever (>38.1°C). Inj site redness.

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Imovax Polio detailed prescribing information

Storage

View Imovax Polio storage conditions for details to ensure optimal shelf-life.

Description

View Imovax Polio description for details of the chemical structure and excipients (inactive components).

Action

View Imovax Polio mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BF03 - poliomyelitis, trivalent, inactivated, whole virus ; Belongs to the class of poliomyelitis viral vaccines.

Regulatory Classification

P₁S₁S₃, A

Presentation/Packing

Form

Imovax Polio vaccine (inj)

Packing/Price

(syringe) 1 dose x 1's

Imovax Polio

Manufacturer:

Sanofi

Distributor:

Zuellig

Four Star